Whole body sodium depletion modifies AT1 mRNA expression and serotonin content in the dorsal raphe nucleus.
Angiotensin II Type 1 Receptor Blockers
/ pharmacology
Animals
Appetite
/ physiology
Dorsal Raphe Nucleus
/ chemistry
Fluorescent Antibody Technique
Gene Expression
/ physiology
Losartan
/ pharmacology
Male
Neurons
/ chemistry
RNA, Messenger
/ analysis
Rats
Rats, Wistar
Receptor, Angiotensin, Type 1
/ analysis
Serotonin
/ analysis
Sodium
/ blood
Subfornical Organ
/ chemistry
Tryptophan Hydroxylase
/ analysis
AT1 receptor
angiotensin II
dorsal raphe nucleus
serotonin
sodium appetite
subfornical organ
Journal
Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
11
12
2017
revised:
19
02
2019
accepted:
21
02
2019
pubmed:
26
2
2019
medline:
22
7
2020
entrez:
26
2
2019
Statut:
ppublish
Résumé
Angiotensin II (Ang II) acts on Ang II type 1 (AT1) receptors located in the organum vasculosum and subfornical organ (SFO) of the lamina terminalis as a main facilitatory mechanism of sodium appetite. The brain serotonin (5-HT) system with soma located in the dorsal raphe nucleus (DRN) provides a main inhibitory mechanism. In the present study, we first investigated the existence of Ang II AT1 receptors in serotonergic DRN neurones. Then, we examined whether whole body sodium depletion affects the gene expression of the AT1a receptor subtype and the presumed functional significance of AT1 receptors. Using confocal microscopy, we found that tryptophan hydroxylase-2 and serotonin neurones express AT1 receptors in the DRN. Immunofluorescence quantification showed a significant reduction in 5-HT content but no change in AT1 receptor expression or AT1/5-HT colocalisation in the DRN after sodium depletion. Whole body sodium depletion also significantly increased Agtr1a mRNA expression in the SFO and DRN. Oral treatment with the AT1 receptor antagonist losartan reversed the changes in Agtr1a expression in the SFO but not the DRN. Losartan injection into either the DRN or the mesencephalic aqueduct had no influence on sodium depletion-induced 0.3 mol L
Substances chimiques
Agtr1a protein, rat
0
Angiotensin II Type 1 Receptor Blockers
0
RNA, Messenger
0
Receptor, Angiotensin, Type 1
0
Serotonin
333DO1RDJY
Sodium
9NEZ333N27
Tryptophan Hydroxylase
EC 1.14.16.4
tph2 protein, rat
EC 1.14.16.4
Losartan
JMS50MPO89
Banques de données
GENBANK
['NM_030985.4', 'NM_017008.4']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12703Informations de copyright
© 2019 British Society for Neuroendocrinology.